Breaking News Instant updates and real-time market news.

BHVN

Biohaven Pharmaceutical

$50.05 /

-0.38 (-0.75%)

06:53
05/20/20
05/20
06:53
05/20/20
06:53

Biohaven withdraws standard rimegepant tablet application with FDA

Biohaven Pharmaceutical disclosed last night that in the first full eight weeks following its launch, Nurtec Orally Dissolving Tablet "continues to demonstrate its differentiation over competitors with the greatest week-over-week growth for new acute migraine treatments during that time period, with over 9,000 prescriptions written to date." It added, "Due to the early success and life-cycle benefits for Nurtec ODT, Biohaven has determined it is in the Company's best interests not to expend the resources to commercialize the standard rimegepant tablet formulation and thus, today officially withdrew the standard rimegepant tablet NDA currently pending with the U.S. Food and Drug Administration. The decision to focus all commercialization efforts on Nurtec ODT and expand the Nurtec ODT label with an sNDA filing for prevention of migraine will allow patients the potential to benefit from a 'dual acting' (acute and prevention) treatment for migraine in a simple to use and best in class ODT formulation. This decision will also allow Biohaven to optimize its resources on increasing market share of the only CGRP-targeting ODT and obviates the need for maintaining a duplicate inventory and control system for two formulations (tablet and ODT)."

BHVN Biohaven Pharmaceutical
$50.05 /

-0.38 (-0.75%)

05/11/20 Cantor Fitzgerald
Biohaven Pharmaceutical price target raised to $82 from $75 at Cantor Fitzgerald
04/17/20 Cowen
Cowen initiates Biohaven Pharmaceutical with Outperform on migraine opportunity
04/17/20 Cowen
Biohaven Pharmaceutical initiated with an Outperform at Cowen
03/31/20 Oppenheimer
Biohaven Pharmaceutical price target lowered to $37 from $48 at Oppenheimer

TODAY'S FREE FLY STORIES

Hot Stocks
Moleculin Biotech recruits first patient in Phase 1 clinical trial of WP1066 » 07:42
06/02/20
06/02
07:42
06/02/20
07:42
MBRX

Moleculin Biotech

$1.17 /

+0.075 (+6.85%)

Moleculin Biotech…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MBRX Moleculin Biotech
$1.17 /

+0.075 (+6.85%)

MBRX Moleculin Biotech
$1.17 /

+0.075 (+6.85%)

04/08/20 Roth Capital
Moleculin can expedite COVID candidate amid less restrictions, says Roth Capital
10/17/19 Oppenheimer
Moleculin Biotech initiated with an Outperform at Oppenheimer
Hot Stocks
Moderna announces new research to be highlighted at Science Day » 07:41
06/02/20
06/02
07:41
06/02/20
07:41
MRNA

Moderna

$62.17 /

+0.72 (+1.17%)

Moderna announced new…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MRNA Moderna
$62.17 /

+0.72 (+1.17%)

MRNA Moderna
$62.17 /

+0.72 (+1.17%)

06/01/20 Goldman Sachs
Goldman keeps $105 target after Moderna COVID vaccine moves to Phase 2
05/26/20 Maxim
ADMA Biologics' use of plasma is 'oldest trick in pandemic playbook', says Maxim
05/20/20 Morgan Stanley
Moderna price target raised to $90 from $37 at Morgan Stanley
05/19/20 Piper Sandler
Piper trims Moderna target to $100 on capital raise dilution
MRNA Moderna
$62.17 /

+0.72 (+1.17%)

MRNA Moderna
$62.17 /

+0.72 (+1.17%)

MRNA Moderna
$62.17 /

+0.72 (+1.17%)

MRNA Moderna
$62.17 /

+0.72 (+1.17%)

Initiation
Ayala Pharmaceuticals initiated with an Outperform at Oppenheimer » 07:41
06/02/20
06/02
07:41
06/02/20
07:41
AYLA

Ayala Pharmaceuticals

$15.30 /

+0.24 (+1.59%)

, BMY

Bristol-Myers

$60.31 /

+0.59 (+0.99%)

Oppenheimer analyst Jay…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BMY Bristol-Myers
$60.31 /

+0.59 (+0.99%)

AYLA Ayala Pharmaceuticals
$15.30 /

+0.24 (+1.59%)

06:15 Today Citi
Ayala Pharmaceuticals initiated with a Buy at Citi
BMY Bristol-Myers
$60.31 /

+0.59 (+0.99%)

05/13/20 Stifel
Bluebird's ide-cel remains approvable despite FDA's 'strict stance,' says Stifel
05/13/20 Piper Sandler
Bluebird should be able to easily address RTF issues, says Piper Sandler
05/12/20 Oppenheimer
Bluebird Bio price target lowered to $111 from $122 at Oppenheimer
04/20/20 Piper Sandler
Exelixis combo approval would increase kidney cancer use, says Piper Sandler
BMY Bristol-Myers
$60.31 /

+0.59 (+0.99%)

BMY Bristol-Myers
$60.31 /

+0.59 (+0.99%)

AYLA Ayala Pharmaceuticals
$15.30 /

+0.24 (+1.59%)

BMY Bristol-Myers
$60.31 /

+0.59 (+0.99%)

BMY Bristol-Myers
$60.31 /

+0.59 (+0.99%)

Recommendations
MongoDB price target raised to $275 from $130 at Barclays » 07:41
06/02/20
06/02
07:41
06/02/20
07:41
MDB

MongoDB

$238.36 /

+5.67 (+2.44%)

Barclays analyst Raimo…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MDB MongoDB
$238.36 /

+5.67 (+2.44%)

MDB MongoDB
$238.36 /

+5.67 (+2.44%)

05/22/20 Stifel
MongoDB price target raised to $225 from $160 at Stifel
04/19/20 Stifel
MongoDB price target raised to $160 from $135 at Stifel
03/18/20 Oppenheimer
MongoDB price target lowered to $140 from $155 at Oppenheimer
03/18/20 DA Davidson
MongoDB price target lowered to $105 from $143 at DA Davidson
MDB MongoDB
$238.36 /

+5.67 (+2.44%)

MDB MongoDB
$238.36 /

+5.67 (+2.44%)

MDB MongoDB
$238.36 /

+5.67 (+2.44%)

Hot Stocks
Dick's Sporting has re-opened approximately 80% of its stores as of 5/30  07:40
06/02/20
06/02
07:40
06/02/20
07:40
DKS

Dick's Sporting

$36.47 /

+0.37 (+1.02%)

 
ShowHide Related Items >><<
DKS Dick's Sporting
$36.47 /

+0.37 (+1.02%)

DKS Dick's Sporting
$36.47 /

+0.37 (+1.02%)

05/28/20 Wedbush
Dick's Sporting price target raised to $33 from $22 at Wedbush
05/11/20 Nomura Instinet
Dick's Sporting price target raised to $33 from $28 at Nomura Instinet
04/28/20 Barclays
Dick's Sporting price target lowered to $35 from $42 at Barclays
03/25/20
Dick's Sporting management to meet with Susquehanna
DKS Dick's Sporting
$36.47 /

+0.37 (+1.02%)

DKS Dick's Sporting
$36.47 /

+0.37 (+1.02%)

DKS Dick's Sporting
$36.47 /

+0.37 (+1.02%)

DKS Dick's Sporting
$36.47 /

+0.37 (+1.02%)

Hot Stocks
VIVUS announces updated agreement with Icahn Enterprises » 07:40
06/02/20
06/02
07:40
06/02/20
07:40
VVUS

VIVUS

$1.12 /

-0.01 (-0.88%)

, IEP

Icahn Enterprises

$49.11 /

-0.76 (-1.52%)

VIVUS (VVUS) announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
VVUS VIVUS
$1.12 /

-0.01 (-0.88%)

IEP Icahn Enterprises
$49.11 /

-0.76 (-1.52%)

VVUS VIVUS
$1.12 /

-0.01 (-0.88%)

03/04/20 Wells Fargo
VIVUS price target lowered to $1.75 from $10 at Wells Fargo
IEP Icahn Enterprises
$49.11 /

-0.76 (-1.52%)

VVUS VIVUS
$1.12 /

-0.01 (-0.88%)

IEP Icahn Enterprises
$49.11 /

-0.76 (-1.52%)

VVUS VIVUS
$1.12 /

-0.01 (-0.88%)

Hot Stocks
Dick's Sporting CEO says company 'in a position of strength' » 07:39
06/02/20
06/02
07:39
06/02/20
07:39
DKS

Dick's Sporting

$36.47 /

+0.37 (+1.02%)

"Although the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
DKS Dick's Sporting
$36.47 /

+0.37 (+1.02%)

DKS Dick's Sporting
$36.47 /

+0.37 (+1.02%)

05/28/20 Wedbush
Dick's Sporting price target raised to $33 from $22 at Wedbush
05/11/20 Nomura Instinet
Dick's Sporting price target raised to $33 from $28 at Nomura Instinet
04/28/20 Barclays
Dick's Sporting price target lowered to $35 from $42 at Barclays
03/25/20
Dick's Sporting management to meet with Susquehanna
DKS Dick's Sporting
$36.47 /

+0.37 (+1.02%)

DKS Dick's Sporting
$36.47 /

+0.37 (+1.02%)

DKS Dick's Sporting
$36.47 /

+0.37 (+1.02%)

DKS Dick's Sporting
$36.47 /

+0.37 (+1.02%)

Recommendations
Broadcom price target raised to $340 from $300 at Susquehanna » 07:39
06/02/20
06/02
07:39
06/02/20
07:39
AVGO

Broadcom

$289.72 /

-2.12 (-0.73%)

Susquehanna analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
AVGO Broadcom
$289.72 /

-2.12 (-0.73%)

AVGO Broadcom
$289.72 /

-2.12 (-0.73%)

05/08/20 DA Davidson
SailPoint price target raised to $24 from $18 at DA Davidson
05/04/20 KeyBanc
Apple cautious iPhone outlook likely a headwind for chip suppliers, says KeyBanc
05/01/20 BTIG
Crowdstrike price target raised to $80 from $67 at BTIG
04/09/20 KeyBanc
KeyBanc remains cautious on Apple supply chain stocks, only recommends Broadcom
AVGO Broadcom
$289.72 /

-2.12 (-0.73%)

AVGO Broadcom
$289.72 /

-2.12 (-0.73%)

AVGO Broadcom
$289.72 /

-2.12 (-0.73%)

AVGO Broadcom
$289.72 /

-2.12 (-0.73%)

Hot Stocks
Uniti Group completes sale of U.S. tower business for $220M » 07:38
06/02/20
06/02
07:38
06/02/20
07:38
UNIT

Uniti Group

$8.74 /

+0.49 (+5.94%)

Uniti Group announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
UNIT Uniti Group
$8.74 /

+0.49 (+5.94%)

UNIT Uniti Group
$8.74 /

+0.49 (+5.94%)

05/12/20 Raymond James
Uniti Group upgraded to Strong Buy from Outperform at Raymond James
05/12/20 Raymond James
Uniti Group upgraded to Strong Buy from Outperform at Raymond James
03/03/20 Raymond James
Uniti Group upgraded to Outperform from Market Perform at Raymond James
03/02/20 Raymond James
Uniti Group upgraded to Outperform from Market Perform at Raymond James
UNIT Uniti Group
$8.74 /

+0.49 (+5.94%)

UNIT Uniti Group
$8.74 /

+0.49 (+5.94%)

Hot Stocks
Hartford Financial, AARP extend auto and home insurance program for AARP members » 07:37
06/02/20
06/02
07:37
06/02/20
07:37
HIG

Hartford Financial

$38.85 /

+0.48 (+1.25%)

Hartford announced an…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
HIG Hartford Financial
$38.85 /

+0.48 (+1.25%)

HIG Hartford Financial
$38.85 /

+0.48 (+1.25%)

05/05/20 Deutsche Bank
Hartford Financial price target lowered to $53 from $63 at Deutsche Bank
04/14/20 Morgan Stanley
Hartford Financial upgraded to Overweight from Equal Weight at Morgan Stanley
04/08/20 RBC Capital
Hartford Financial price target lowered to $39 from $66 at RBC Capital
04/01/20 Wells Fargo
Hartford Financial upgraded to Overweight from Equal Weight at Wells Fargo
HIG Hartford Financial
$38.85 /

+0.48 (+1.25%)

HIG Hartford Financial
$38.85 /

+0.48 (+1.25%)

HIG Hartford Financial
$38.85 /

+0.48 (+1.25%)

HIG Hartford Financial
$38.85 /

+0.48 (+1.25%)

Recommendations
Zynga price target raised to $9.50 from $7.50 at Barclays » 07:37
06/02/20
06/02
07:37
06/02/20
07:37
ZNGA

Zynga

$9.65 /

+0.505 (+5.53%)

Barclays analyst Mario Lu…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ZNGA Zynga
$9.65 /

+0.505 (+5.53%)

ZNGA Zynga
$9.65 /

+0.505 (+5.53%)

06:57 Today Benchmark
Zynga price target raised to $11 from $9 at Benchmark
04:56 Today Piper Sandler
Zynga price target raised to $11 from $8.50 at Piper Sandler
06/01/20 Wedbush
Zynga price target raised to $11.50 from $9.25 at Wedbush
06/01/20 Baird
Baird ups Zynga target to $10 from $9, says Peak good fit
ZNGA Zynga
$9.65 /

+0.505 (+5.53%)

ZNGA Zynga
$9.65 /

+0.505 (+5.53%)

ZNGA Zynga
$9.65 /

+0.505 (+5.53%)

ZNGA Zynga
$9.65 /

+0.505 (+5.53%)

Hot Stocks
Aduro Biotech presents nonclinical, Phase 1 healthy volunteer data for BION-1301 » 07:37
06/02/20
06/02
07:37
06/02/20
07:37
ADRO

Aduro Biotech

$3.38 /

+0.1 (+3.05%)

Aduro Biotech announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ADRO Aduro Biotech
$3.38 /

+0.1 (+3.05%)

ADRO Aduro Biotech
$3.38 /

+0.1 (+3.05%)

01/10/20 Cowen
Aduro downgraded to Market Perform on limited visibility at Cowen
01/10/20 Cowen
Aduro Biotech downgraded to Market Perform from Outperform at Cowen
12/18/19 H.C. Wainwright
Aduro Biotech price target lowered to $4 from $7 at H.C. Wainwright
12/18/19 William Blair
Aduro Biotech downgraded to Market Perform from Outperform at William Blair
ADRO Aduro Biotech
$3.38 /

+0.1 (+3.05%)

ADRO Aduro Biotech
$3.38 /

+0.1 (+3.05%)

Hot Stocks
Dick's Sporting says SSS down 4% through first four weeks of Q2 » 07:37
06/02/20
06/02
07:37
06/02/20
07:37
DKS

Dick's Sporting

$36.47 /

+0.37 (+1.02%)

Lauren Hobart, President,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
DKS Dick's Sporting
$36.47 /

+0.37 (+1.02%)

DKS Dick's Sporting
$36.47 /

+0.37 (+1.02%)

05/28/20 Wedbush
Dick's Sporting price target raised to $33 from $22 at Wedbush
05/11/20 Nomura Instinet
Dick's Sporting price target raised to $33 from $28 at Nomura Instinet
04/28/20 Barclays
Dick's Sporting price target lowered to $35 from $42 at Barclays
03/25/20
Dick's Sporting management to meet with Susquehanna
DKS Dick's Sporting
$36.47 /

+0.37 (+1.02%)

DKS Dick's Sporting
$36.47 /

+0.37 (+1.02%)

DKS Dick's Sporting
$36.47 /

+0.37 (+1.02%)

DKS Dick's Sporting
$36.47 /

+0.37 (+1.02%)

Hot Stocks
SAIC wins $60M contract for torpedo testing services for U.S. Navy » 07:36
06/02/20
06/02
07:36
06/02/20
07:36
SAIC

SAIC

$89.93 /

+1.73 (+1.96%)

The U.S. Navy awarded…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SAIC SAIC
$89.93 /

+1.73 (+1.96%)

SAIC SAIC
$89.93 /

+1.73 (+1.96%)

05/19/20 Wells Fargo
SAIC price target raised to $105 from $85 at Wells Fargo
04/20/20
Fly Intel: Top five analyst upgrades
04/20/20 Goldman Sachs
Booz Allen downgraded to Neutral from Buy at Goldman Sachs
04/20/20 Goldman Sachs
SAIC upgraded to Buy from Neutral at Goldman Sachs
SAIC SAIC
$89.93 /

+1.73 (+1.96%)

SAIC SAIC
$89.93 /

+1.73 (+1.96%)

Recommendations
Trip.com Group price target raised to $32 from $30 at Barclays » 07:35
06/02/20
06/02
07:35
06/02/20
07:35
TCOM

Trip.com Group

$25.90 /

-0.69 (-2.59%)

Barclays analyst Gregory…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TCOM Trip.com Group
$25.90 /

-0.69 (-2.59%)

TCOM Trip.com Group
$25.90 /

-0.69 (-2.59%)

05/29/20 Nomura Instinet
Trip.com Group upgraded to Buy from Neutral at Nomura Instinet
05/29/20 Nomura Instinet
Trip.com Group upgraded to Buy from Neutral at Nomura Instinet
05/05/20 Mizuho
Trip.com Group price target lowered to $30 from $32 at Mizuho
04/28/20 New Street
Trip.com Group upgraded to Buy from Neutral at New Street
TCOM Trip.com Group
$25.90 /

-0.69 (-2.59%)

TCOM Trip.com Group
$25.90 /

-0.69 (-2.59%)

Hot Stocks
CME Group reaches ADV of 17.9M contracts in May » 07:35
06/02/20
06/02
07:35
06/02/20
07:35
CME

CME Group

$182.25 /

-0.35 (-0.19%)

CME Group reported May…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CME CME Group
$182.25 /

-0.35 (-0.19%)

CME CME Group
$182.25 /

-0.35 (-0.19%)

04/28/20 JPMorgan
CME Group interest rate business at risk, says JPMorgan
04/21/20 Oppenheimer
Oppenheimer would be 'patient and opportunistic' buyers of CME Group shares
04/20/20 Berenberg
IntercontinentalExchange upgraded to Buy from Hold at Berenberg
04/14/20 Keefe Bruyette
CME Group downgraded to Underperform on volume risk at Keefe Bruyette
CME CME Group
$182.25 /

-0.35 (-0.19%)

CME CME Group
$182.25 /

-0.35 (-0.19%)

CME CME Group
$182.25 /

-0.35 (-0.19%)

CME CME Group
$182.25 /

-0.35 (-0.19%)

Hot Stocks
Aduro Biotech to acquire all oustanding capital stock of Chinook Therapeutics » 07:35
06/02/20
06/02
07:35
06/02/20
07:35
ADRO

Aduro Biotech

$3.38 /

+0.1 (+3.05%)

Aduro Biotech and Chinook…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ADRO Aduro Biotech
$3.38 /

+0.1 (+3.05%)

ADRO Aduro Biotech
$3.38 /

+0.1 (+3.05%)

01/10/20 Cowen
Aduro downgraded to Market Perform on limited visibility at Cowen
01/10/20 Cowen
Aduro Biotech downgraded to Market Perform from Outperform at Cowen
12/18/19 H.C. Wainwright
Aduro Biotech price target lowered to $4 from $7 at H.C. Wainwright
12/18/19 William Blair
Aduro Biotech downgraded to Market Perform from Outperform at William Blair
ADRO Aduro Biotech
$3.38 /

+0.1 (+3.05%)

ADRO Aduro Biotech
$3.38 /

+0.1 (+3.05%)

Hot Stocks
Dick's Sporting reports Q1 ecommerce sales up 110% » 07:34
06/02/20
06/02
07:34
06/02/20
07:34
DKS

Dick's Sporting

$36.47 /

+0.37 (+1.02%)

eCommerce sales increased…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
DKS Dick's Sporting
$36.47 /

+0.37 (+1.02%)

DKS Dick's Sporting
$36.47 /

+0.37 (+1.02%)

05/28/20 Wedbush
Dick's Sporting price target raised to $33 from $22 at Wedbush
05/11/20 Nomura Instinet
Dick's Sporting price target raised to $33 from $28 at Nomura Instinet
04/28/20 Barclays
Dick's Sporting price target lowered to $35 from $42 at Barclays
03/25/20
Dick's Sporting management to meet with Susquehanna
DKS Dick's Sporting
$36.47 /

+0.37 (+1.02%)

DKS Dick's Sporting
$36.47 /

+0.37 (+1.02%)

DKS Dick's Sporting
$36.47 /

+0.37 (+1.02%)

DKS Dick's Sporting
$36.47 /

+0.37 (+1.02%)

Hot Stocks
Dick's Sporting reports total inventory down 2.1% at end of Q1  07:34
06/02/20
06/02
07:34
06/02/20
07:34
DKS

Dick's Sporting

$36.47 /

+0.37 (+1.02%)

 
ShowHide Related Items >><<
DKS Dick's Sporting
$36.47 /

+0.37 (+1.02%)

DKS Dick's Sporting
$36.47 /

+0.37 (+1.02%)

05/28/20 Wedbush
Dick's Sporting price target raised to $33 from $22 at Wedbush
05/11/20 Nomura Instinet
Dick's Sporting price target raised to $33 from $28 at Nomura Instinet
04/28/20 Barclays
Dick's Sporting price target lowered to $35 from $42 at Barclays
03/25/20
Dick's Sporting management to meet with Susquehanna
DKS Dick's Sporting
$36.47 /

+0.37 (+1.02%)

DKS Dick's Sporting
$36.47 /

+0.37 (+1.02%)

DKS Dick's Sporting
$36.47 /

+0.37 (+1.02%)

DKS Dick's Sporting
$36.47 /

+0.37 (+1.02%)

Recommendations
CSX price target raised to $76 from $67 at Barclays » 07:33
06/02/20
06/02
07:33
06/02/20
07:33
CSX

CSX

$70.83 /

-0.74 (-1.03%)

Barclays analyst Brandon…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CSX CSX
$70.83 /

-0.74 (-1.03%)

CSX CSX
$70.83 /

-0.74 (-1.03%)

05/20/20 UBS
CSX upgraded to Buy from Neutral at UBS
04/24/20 Argus
CSX price target lowered to $72 from $84 at Argus
04/15/20 Wells Fargo
CSX price target lowered to $66 from $76 at Wells Fargo
04/08/20
Fly Intel: Top five analyst upgrades
CSX CSX
$70.83 /

-0.74 (-1.03%)

CSX CSX
$70.83 /

-0.74 (-1.03%)

CSX CSX
$70.83 /

-0.74 (-1.03%)

CSX CSX
$70.83 /

-0.74 (-1.03%)

Hot Stocks
Dick's Sporting not providing an updated outlook at this time » 07:33
06/02/20
06/02
07:33
06/02/20
07:33
DKS

Dick's Sporting

$36.47 /

+0.37 (+1.02%)

As previously announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
DKS Dick's Sporting
$36.47 /

+0.37 (+1.02%)

DKS Dick's Sporting
$36.47 /

+0.37 (+1.02%)

05/28/20 Wedbush
Dick's Sporting price target raised to $33 from $22 at Wedbush
05/11/20 Nomura Instinet
Dick's Sporting price target raised to $33 from $28 at Nomura Instinet
04/28/20 Barclays
Dick's Sporting price target lowered to $35 from $42 at Barclays
03/25/20
Dick's Sporting management to meet with Susquehanna
DKS Dick's Sporting
$36.47 /

+0.37 (+1.02%)

DKS Dick's Sporting
$36.47 /

+0.37 (+1.02%)

DKS Dick's Sporting
$36.47 /

+0.37 (+1.02%)

DKS Dick's Sporting
$36.47 /

+0.37 (+1.02%)

Initiation
Pacific Biosciences assumed with an Overweight at Cantor Fitzgerald » 07:33
06/02/20
06/02
07:33
06/02/20
07:33
PACB

Pacific Biosciences

$3.58 /

+0.055 (+1.56%)

Cantor Fitzgerald analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
PACB Pacific Biosciences
$3.58 /

+0.055 (+1.56%)

PACB Pacific Biosciences
$3.58 /

+0.055 (+1.56%)

06/01/20 Cantor Fitzgerald
Pacific Biosciences assumed with an Overweight at Cantor Fitzgerald
05/07/20 Piper Sandler
Pacific Biosciences price target lowered to $6 from $7 at Piper Sandler
03/19/20 Cantor Fitzgerald
Pacific Biosciences verdict won't have material impact, says Cantor Fitzgerald
03/09/20 Cantor Fitzgerald
Pacific Biosciences assumed with an Overweight at Cantor Fitzgerald
PACB Pacific Biosciences
$3.58 /

+0.055 (+1.56%)

PACB Pacific Biosciences
$3.58 /

+0.055 (+1.56%)

Hot Stocks
Aduro Biotech, Chinook Therapeutics announce definitive merger agreement  07:32
06/02/20
06/02
07:32
06/02/20
07:32
ADRO

Aduro Biotech

$3.38 /

+0.1 (+3.05%)

 
ShowHide Related Items >><<
ADRO Aduro Biotech
$3.38 /

+0.1 (+3.05%)

ADRO Aduro Biotech
$3.38 /

+0.1 (+3.05%)

01/10/20 Cowen
Aduro downgraded to Market Perform on limited visibility at Cowen
01/10/20 Cowen
Aduro Biotech downgraded to Market Perform from Outperform at Cowen
12/18/19 H.C. Wainwright
Aduro Biotech price target lowered to $4 from $7 at H.C. Wainwright
12/18/19 William Blair
Aduro Biotech downgraded to Market Perform from Outperform at William Blair
ADRO Aduro Biotech
$3.38 /

+0.1 (+3.05%)

ADRO Aduro Biotech
$3.38 /

+0.1 (+3.05%)

Earnings
Dick's Sporting reports Q1 EPS ($1.71) with expenses, consensus (57c) » 07:32
06/02/20
06/02
07:32
06/02/20
07:32
DKS

Dick's Sporting

$36.47 /

+0.37 (+1.02%)

Reports Q1 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
DKS Dick's Sporting
$36.47 /

+0.37 (+1.02%)

DKS Dick's Sporting
$36.47 /

+0.37 (+1.02%)

05/28/20 Wedbush
Dick's Sporting price target raised to $33 from $22 at Wedbush
05/11/20 Nomura Instinet
Dick's Sporting price target raised to $33 from $28 at Nomura Instinet
04/28/20 Barclays
Dick's Sporting price target lowered to $35 from $42 at Barclays
03/25/20
Dick's Sporting management to meet with Susquehanna
DKS Dick's Sporting
$36.47 /

+0.37 (+1.02%)

DKS Dick's Sporting
$36.47 /

+0.37 (+1.02%)

DKS Dick's Sporting
$36.47 /

+0.37 (+1.02%)

DKS Dick's Sporting
$36.47 /

+0.37 (+1.02%)

Hot Stocks
BofA announces $1B in initiatives to assist people and communities of color » 07:32
06/02/20
06/02
07:32
06/02/20
07:32
BAC

Bank of America

$24.63 /

+0.535 (+2.22%)

Bank of America announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BAC Bank of America
$24.63 /

+0.535 (+2.22%)

BAC Bank of America
$24.63 /

+0.535 (+2.22%)

04/16/20 DA Davidson
Bank of America price target raised to $26 from $24 at DA Davidson
04/16/20 BMO Capital
Bank of America price target lowered to $24 from $26 at BMO Capital
04/14/20 Societe Generale
Societe Generale double upgrades five global I-banks ahead of 'next bull run'
04/14/20 Societe Generale
Bank of America upgraded to Hold from Sell at Societe Generale
BAC Bank of America
$24.63 /

+0.535 (+2.22%)

BAC Bank of America
$24.63 /

+0.535 (+2.22%)

BAC Bank of America
$24.63 /

+0.535 (+2.22%)

BAC Bank of America
$24.63 /

+0.535 (+2.22%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.